Abstract |
Phenolphthalein has carcinogenic activity, causing malignant lymphomas in B6C3F1 mice at a dietary dose of 3000 ppm in a 2-year carcinogenicity study and in heterozygous p53-deficient female mice at the same dose in a 6-month study. To examine whether phenolphthalein carcinogenic potential can be detected in male and female transgenic (Tg) mice carrying the human c-Ha-ras gene (rasH2 mice) and their wild-type littermates (non-Tg mice), a diet containing 3000, 6000 or 12000 ppm was given for 6 months. Unequivocal induction of neoplastic lesions was not apparent, suggesting that rasH2 mice are resistant to the induction of malignant lymphomas by the treatment of phenolphthalein.
|
Authors | T Koujitani, K Yasuhara, T Usui, T Nomura, H Onodera, H Takagi, M Hirose, K Mitsumori |
Journal | Cancer letters
(Cancer Lett)
Vol. 152
Issue 2
Pg. 211-6
(May 01 2000)
ISSN: 0304-3835 [Print] Ireland |
PMID | 10773414
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carcinogens
- MAS1 protein, human
- Proto-Oncogene Mas
- Phenolphthalein
|
Topics |
- Adenoma, Liver Cell
(chemically induced)
- Animals
- Body Weight
(drug effects)
- Carcinogenicity Tests
(methods)
- Carcinogens
(toxicity)
- Female
- Genes, ras
(genetics)
- Hemangiosarcoma
(chemically induced)
- Humans
- Lung Neoplasms
(chemically induced)
- Lymphoma
(chemically induced)
- Male
- Mice
- Mice, Transgenic
- Phenolphthalein
(toxicity)
- Proto-Oncogene Mas
- Splenic Neoplasms
(chemically induced)
- Thymus Neoplasms
(chemically induced)
- Time Factors
|